Citations

Showing 10 of 108119 citations.

The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way
Colmenero, Jordi , Berenguer, Marina , Watt, Kymberly D. , Berenguer, Marina , Colmenero, Jordi

Mayo Clinic

Transplantation | December 14, 2021 | Volume: 106 | Issue: 1 | Pages: e1-e2

10.1097/tp.0000000000003994 | PMID 34905757 Get It

The International Liver Transplantation Society and the Spanish Society of Liver Transplantation consensus conference on extrahepatic cancer and liver transplantation (LT) was held on January 28–30, 2021. Working groups were organized to focus on one topic and develop evidence-based recommendations specifically addressing (a) nonhepatic cancer in LT candidates, (b) de novo malignancies after LT, (c) prevention and management of donor-derived malignancies after LT, and (d) nonhepatic cancer in the pediatric population. All consensus conference attendees voted on the recommendations proposed as well as the quality of evidence according to the Grading of Recommendations, Assessment, Development and Evaluation system.
UME-to-GME PandEMonium in COVID-19: Large-Scale Implementation of a Virtual ACGME Milestone-Based Curriculum for Senior Medical Students Matched Into Emergency Medicine
McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Karalius, Vytas P., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L., Karalius, Vytas P. , Husain, Abbas , McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L.

Mayo Clinic

Journal of Graduate Medical Education | December 14, 2021 | Volume: 13 | Issue: 6 | Pages: 848-857

10.4300/jgme-d-21-00620.1 | PMID 35070098 Get It

ABSTRACT Background The COVID-19 pandemic displaced newly matched emergency medicine “pre-interns” from in-person educational experiences at the end of medical school. This called for novel remote teaching modalities. Objective This study assesses effectiveness of a multisite Accreditation Council for Graduate Medical Education (ACGME) sub-competency-based curricular implementation on Slack during the first wave of the COVID-19 pandemic in the United States. Methods Emergency medicine residency programs were recruited via national organization listservs. Programs designated instructors to manage communications and teaching for the senior medical students who had matched to their programs (pre-interns) in spring/summer 2020. Pre- and post-surveys of trainees and instructors assessed perceived preparedness for residency, perceived effectiveness of common virtual educational modalities, and concern for the pandemic's effects on medical education utilizing a Likert scale of 1 (very unconcerned) to 5 (very concerned). Data were analyzed using descriptive statistics and the t test. Results Of 276 possible residency programs, 28 enrolled. Of 324 possible pre-interns, 297 (91.7%) completed pre-surveys in April/May and 249 (76.9%) completed post-surveys in June/July. The median weeks since performing a physical examination was 8 (IQR 7–12), since attending in-person didactics was 10 (IQR 8–15) and of rotation displacement was 4 (IQR 2–6). Perceived preparedness increased both overall and for 14 of 21 ACGME Milestone topics taught. Instructors reported higher mean concern (4.32, 95% CI 4.23–4.41) than pre-interns (2.88, 95% CI 2.74–3.02) regarding the pandemic's negative effects on medical education. Conclusions Pre-interns reported improvements in residency preparedness after participating in this ACGME sub-competency-based curriculum on Slack.
Virtual Learning in Graduate Medical Education: Applying Learning Theory for Effective Educational Videos
Farr, Ellen, Roth, Elliot, Farr, Ellen , Roth, Elliot

Mayo Clinic

Journal of Graduate Medical Education | December 14, 2021 | Volume: 13 | Issue: 6 | Pages: 757-760

10.4300/jgme-d-21-00245.1 | PMID 35070084 Get It

Building a precise machine-specific time structure of the spot and energy delivery model for a cyclotron-based proton therapy system
Zhao, Lewei , Zheng, Weili , Shen, Jiajian , Lee, Andrew , Yan, Di , Deraniyagala, Rohan, Stevens, Craig , Tang, Shikui, Ding, Xuanfeng , Shen, Jiajian , Liu, Gang , Li, Xiaoqiang

Mayo Clinic

Physics in Medicine & Biology | December 14, 2021 | Volume: 67 | Issue: 1 | Pages: 01NT01

10.1088/1361-6560/ac431c | PMID 34905732 Get It

Abstract Objective . We proposed an experimental approach to build a precise machine-specific beam delivery time (BDT) prediction and delivery sequence model for standard, volumetric, and layer repainting delivery based on a cyclotron accelerator system. Approach . Test fields and clinical treatment plans’ log files were used to experimentally derive three main beam delivery parameters that impacted BDT: energy layer switching time (ELST), spot switching time, and spot drill time. This derived machine-specific model includes standard, volumetric, and layer repainting delivery sequences. A total of 103 clinical treatment fields were used to validate the model. Main results . The study found that ELST is not stochastic in this specific machine. Instead, it is actually the data transmission time or energy selection time, whichever takes longer. The validation showed that the accuracy of each component of the BDT matches well between machine log files and the model’s prediction. The average total BDT was about (−0.74 ± 3.33)% difference compared to the actual treatment log files, which is improved from the current commercial proton therapy system’s prediction (67.22%±26.19%). Significance . An accurate BDT prediction and delivery sequence model was established for an cyclotron-based proton therapy system IBA ProteusPLUS ® . Most institutions could adopt this method to build a machine-specific model for their own proton system.
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Vizza, Carmine Dario , Benza, Raymond L. , White, R. James , Adir, Yochai , Andreassen, Arne K., Balasubramanian, Vijay , Bartolome, Sonja, Carlsen, Jørn , Camacho, Rafael Enrique Conde, Ford, H. James , Humbert, Marc , Naeije, Robert , Orfanos, Stylianos E. , Oudiz, Ronald J. , Perrone, Sergio V. , Shlobin, Oksana A. , Torres, Fernando , Vachiéry, Jean Luc, Wang, Kuo‐Yang , Liu, Yan , Golden, Gil, Matsubara, Hiromi , Benza, Raymond L. , Oudiz, Ronald , Lang, Iréne , Badagliacca, Roberto , Rosenkranz, Stephan , Andreassen, Arne K., Blanco, Isabel , Bourge, Robert C. , Camacho, Rafael Enrique Conde , D’Alto, Michele , Farber, Harrison W. , Frantz, Robert P. , Ghio, Stefano , Gomberg‐Maitland, Mardi , Simon, Marc A. , Sitbon, Olivier , Vachiéry, Jean‐Luc , Yacoub, Magdi Habib

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | December 14, 2021 | Volume: 205 | Issue: 7 | Pages: 751-760

10.1164/rccm.202109-2079pp | PMID 34905704 Get It

Abstract Despite numerous therapeutic advances in pulmonary arterial hypertension, patients continue to suffer high morbidity and mortality, particularly considering a median age of 50 years. This article explores whether early, robust reduction of right ventricular afterload would facilitate substantial improvement in right ventricular function and thus whether afterload reduction should be a treatment goal for pulmonary arterial hypertension. The earliest clinical studies of prostanoid treatment in pulmonary arterial hypertension demonstrated an important link between lowering mean pulmonary arterial pressure (or pulmonary vascular resistance) and improved survival. Subsequent studies of oral monotherapy or sequential combination therapy demonstrated smaller reductions in mean pulmonary arterial pressure and pulmonary vascular resistance. More recently, retrospective reports of initial aggressive prostanoid treatment or initial combination oral and parenteral therapy have shown marked afterload reduction along with significant improvements in right ventricular function. Some data suggest that reaching threshold levels for pressure or resistance (components of right ventricular afterload) may be key to interrupting the self-perpetuating injury of pulmonary vascular disease in pulmonary arterial hypertension and could translate into improved long-term clinical outcomes. Based on these clues, the authors postulate that improved clinical outcomes might be achieved by targeting significant afterload reduction with initial oral combination therapy and early parenteral prostanoids.
Tazemetostat: a treatment option for relapsed/refractory follicular lymphoma
Ansell, Stephen M. , Mondello, Patrizia

Mayo Clinic

Expert Opinion on Pharmacotherapy | December 14, 2021 | Volume: 23 | Issue: 3 | Pages: 295-301

10.1080/14656566.2021.2014815 | PMID 34904909 Get It

The year in cardiovascular medicine 2021: digital health and innovation
Vardas, Panos , Asselbergs, Folkert W. , Smeden, Maarten van , Friedman, Paul A. , Vardas, Panos E , van Smeden, Maarten

Mayo Clinic

European Heart Journal | December 14, 2021 | Volume: 43 | Issue: 4 | Pages: 271-279

10.1093/eurheartj/ehab874 | PMID 34974610 Get It

Abstract This article presents some of the most important developments in the field of digital medicine that have appeared over the last 12 months and are related to cardiovascular medicine. The article consists of three main sections, as follows: (i) artificial intelligence-enabled cardiovascular diagnostic tools, techniques, and methodologies, (ii) big data and prognostic models for cardiovascular risk protection, and (iii) wearable devices in cardiovascular risk assessment, cardiovascular disease prevention, diagnosis, and management. To conclude the article, the authors present a brief further prospective on this new domain, highlighting existing gaps that are specifically related to artificial intelligence technologies, such as explainability, cost-effectiveness, and, of course, the importance of proper regulatory oversight for each clinical implementation.
Diagnosis, risk stratification and management of myocarditis
Müller, M., Heidecker, Bettina , Müller, Melina , Heidecker, Bettina , Cooper, Leslie T.

Mayo Clinic

Heart | December 14, 2021 | Volume: 108 | Issue: 18 | Pages: 1486-1497

10.1136/heartjnl-2021-319027 | PMID 34907088 Get It

Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond
Usón, Pedro Luiz Serrano , Uson Junior, Pedro Luiz Serrano, Uson, Pedro L S , Borad, Mitesh J.

Mayo Clinic

Expert Opinion on Investigational Drugs | December 14, 2021 | Volume: 31 | Issue: 1 | Pages: 125-131

10.1080/13543784.2022.2017882 | PMID 34904492 Get It